Cerebrospinal Fluid Amyloid Beta (1-42) Protein Profile (Screening)

Why This Test Is Done

Your healthcare provider may order this test if you have symptoms like memory loss, confusion, or other cognitive changes that could suggest conditions like Alzheimer’s disease or other brain-related disorders. It may also be used in research or diagnostic evaluations for suspected brain amyloidosis or related conditions.

What to Expect Before the Test

You’ll have a small needle inserted into your lower back to collect a sample of cerebrospinal fluid. This is typically done in a hospital or clinic setting. You may feel mild pressure or discomfort, but it usually doesn’t cause significant pain. You’ll be asked to lie still for a short time afterward to avoid any bruising.

What the Test Measures

The test measures specific proteins called amyloid beta peptides (particularly amyloid beta 1-42) in your CSF. These proteins are fragments of a larger protein that can form plaques in the brain, associated with conditions like Alzheimer’s disease. Lower-than-expected levels may indicate a higher risk of these conditions.

What the Results Mean

Results are interpreted by a healthcare provider based on your symptoms, medical history, and other tests. While specific reference ranges aren’t provided here, very low levels of amyloid beta 1-42 in CSF are often linked to Alzheimer’s disease or other neurodegenerative disorders. Higher-than-expected levels may suggest other conditions or normal variations.